- Home
- TSHA vs XYF Comparison
TSHA vs XYF Comparison
Compare TSHA & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- XYF
- Stock Information
- Founded
- TSHA 2019
- XYF 2014
- Country
- TSHA United States
- XYF China
- Employees
- TSHA N/A
- XYF N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- XYF Finance: Consumer Services
- Sector
- TSHA Health Care
- XYF Finance
- Exchange
- TSHA Nasdaq
- XYF Nasdaq
- Market Cap
- TSHA 334.1M
- XYF 535.8M
- IPO Year
- TSHA 2020
- XYF 2018
- Fundamental
- Price
- TSHA $1.72
- XYF $11.69
- Analyst Decision
- TSHA Strong Buy
- XYF
- Analyst Count
- TSHA 8
- XYF 0
- Target Price
- TSHA $6.63
- XYF N/A
- AVG Volume (30 Days)
- TSHA 1.5M
- XYF 117.0K
- Earning Date
- TSHA 02-26-2025
- XYF 03-25-2025
- Dividend Yield
- TSHA N/A
- XYF 3.02%
- EPS Growth
- TSHA N/A
- XYF 2.79
- EPS
- TSHA N/A
- XYF 3.88
- Revenue
- TSHA $8,333,000.00
- XYF $763,521,851.00
- Revenue This Year
- TSHA N/A
- XYF N/A
- Revenue Next Year
- TSHA N/A
- XYF N/A
- P/E Ratio
- TSHA N/A
- XYF $2.90
- Revenue Growth
- TSHA N/A
- XYF 16.99
- 52 Week Low
- TSHA $1.19
- XYF $3.48
- 52 Week High
- TSHA $4.32
- XYF $12.37
- Technical
- Relative Strength Index (RSI)
- TSHA 54.31
- XYF 66.33
- Support Level
- TSHA $1.66
- XYF $10.58
- Resistance Level
- TSHA $1.77
- XYF $11.90
- Average True Range (ATR)
- TSHA 0.11
- XYF 0.74
- MACD
- TSHA 0.01
- XYF 0.05
- Stochastic Oscillator
- TSHA 47.62
- XYF 91.80
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.